An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures
Clinical trial NCT00372528 · TERMINATED
Trial details
- NCT number
- NCT00372528
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2011-10-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.